Vaishali Pharma Limited

Vaishali Pharma Limited

Vaishali Pharma Limited has informed the National Stock Exchange of India about the listing and admission to dealings of 45,37,865 equity shares of face value ₹2/- each, allotted on a preferential basis, with effect from October 16, 2026. The shares are under lock-in up to April 30, 2027.

Vaishali Pharma Limited

Vaishali Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018. The company has certified that the details of securities dematerialized/rematerialized during the Second Quarter ended 30th September, 2026 have been furnished to the Stock Exchange where the shares of the Company are listed.

Vaishali Pharma Limited

Vaishali Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, for the purpose of considering Un-audited Financial Result for the Second Quarter and Half Year Ended 30th September, 2026.

Vaishali Pharma Limited

Vaishali Pharma Limited has submitted the Exchange a copy Scrutinizers report of Annual General Meeting held on September 24, 2026, and informed the Exchange regarding voting results.

Vaishali Pharma Limited

Vaishali Pharma Limited held its 19th Annual General Meeting on September 24, 2026, through video conferencing. The meeting was attended by 63 members, and resolutions were passed through remote e-voting. The company's audited financial statements for the year ended March 31, 2026, were adopted, and Mrs. Jagruti Atul Vasani was re-appointed as a director.

Vaishali Pharma Limited

Vaishali Pharma Limited has received listing approval from the National Stock Exchange of India Limited for 45,37,865 equity shares allotted on a preferential basis.

Vaishali Pharma Limited

Vaishali Pharma Limited has informed the Exchange about a newspaper publication related to a public notice regarding a property dispute and a notice of the 19th Annual General Meeting.

Vaishali Pharma Limited

Vaishali Pharma Limited has announced a book closure for its 19th Annual General Meeting (AGM) from September 18-24, 2026, with e-voting to be held from September 21-23, 2026.

Vaishali Pharma Limited

Vaishali Pharma Limited has announced the record date for its 19th Annual General Meeting, which will be held on September 24, 2026. The record date is September 17, 2026, and the company will provide electronic voting facilities for its members.

Vaishali Pharma Limited

Vaishali Pharma Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 24, 2026. The meeting will be held through Video Conferencing and Other Audio-Visual Means (VC/OAVM). The Registered Office of the Company shall be deemed to be the venue for the AGM.

Vaishali Pharma Limited

Vaishali Pharma Limited has published an advertisement in newspapers for its un-audited financial results for the first quarter ended June 30, 2026, as per SEBI listing regulations.

Vaishali Pharma Limited

Vaishali Pharma Limited has informed the Exchange about the resignation of a Director/KMP/SMP.

Vaishali Pharma Limited

Vaishali Pharma Limited has informed the Exchange about the resignation of a Director/KMP/SMP.

Vaishali Pharma Limited

Vaishali Pharma Limited has informed the Exchange about the resignation of a Director/KMP/SMP, but no further details are provided.

Vaishali Pharma Limited

Vaishali Pharma Limited has informed the Exchange regarding the resignation of Bhaveshkumar Popatlal Upadhyay as Non-Executive Independent Director of the company with effect from August 14, 2026.

Vaishali Pharma Limited

Vaishali Pharma Limited has submitted its unaudited financial results for the first quarter ended June 30, 2026, along with a limited review report. The board of directors has also approved the annual report and director's report for the financial year 2025-26, and convened the 19th Annual General Meeting to be held on September 24, 2026.

Vaishali Pharma Limited

Vaishali Pharma Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming that the said regulation is not applicable to the company for the quarter ended on 30th June 2026.

Vaishali Pharma Limited

Vaishali Pharma Limited has held a board meeting on July 08, 2026, but no specific outcomes or decisions have been disclosed.

Vaishali Pharma Limited

Vaishali Pharma Limited has submitted the Exchange a copy Scrutinizer's report of Postal Ballot. The company has informed the Exchange regarding voting results for the re-appointment of Mr. Pratik Vikram Jakhelia, Mr. Atul Arvind Vasani, and Mrs. Jagruti Vasani as Independent Director, Managing Director, and Whole-Time Director respectively. All resolutions were passed with over 99% approval.

Vaishali Pharma Limited

Vaishali Pharma Limited has informed the Exchange about the allotment of 45,37,865 equity shares at an issue price of Rs. 20 per share on a preferential basis to Kesar Pharma Limited for consideration other than cash, as discharge of the non-cash consideration for the subscription of 26.95% of the proposed total issued, subscribed and paid-up equity share capital of Kesar Pharma Limited.